Total submissions: 12
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ce |
RCV000416130 | SCV000493483 | benign | not provided | 2024-08-01 | criteria provided, single submitter | clinical testing | GAN: BS1, BS2 |
Gene |
RCV000416130 | SCV000513109 | likely benign | not provided | 2020-08-31 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 20981092, 21356581, 27884173, 14718689) |
Center for Pediatric Genomic Medicine, |
RCV000416130 | SCV000610799 | likely benign | not provided | 2017-09-25 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000555529 | SCV000640431 | benign | Giant axonal neuropathy 1 | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000555529 | SCV001276372 | likely benign | Giant axonal neuropathy 1 | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
Inherited Neuropathy Consortium | RCV000555529 | SCV000929152 | uncertain significance | Giant axonal neuropathy 1 | no assertion criteria provided | literature only | ||
Clinical Genetics, |
RCV000416130 | SCV001921307 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000416130 | SCV001930054 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000416130 | SCV001974434 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Laboratory of Diagnostic Genome Analysis, |
RCV000416130 | SCV002035426 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Inherited Neuropathy Consortium Ii, |
RCV000555529 | SCV004174517 | uncertain significance | Giant axonal neuropathy 1 | 2016-01-06 | no assertion criteria provided | literature only | |
Prevention |
RCV003912594 | SCV004736611 | likely benign | GAN-related disorder | 2019-04-17 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |